Hunan University of Chinese Medicine, Changsha, China.
The Affiliated Hospital of Hunan Academy of Traditional Chinese Medicine, Changsha, China.
Medicine (Baltimore). 2023 Jun 16;102(24):e33945. doi: 10.1097/MD.0000000000033945.
Chondromalacia patellae (CP) is a common and main cause of knee pain, the prevalence of the disease in the general population is as high as 36.2%, especially in middle-aged patients aged between 30 and 40 years (up to 50%). The use of manual therapy (MT) to dredge the meridians and muscles around the knee joint and stimulate the relevant acupoints can play vital roles in relieving pain and improving function. The purpose of this study is to assess the effectiveness, safety and further comprehensively, completely and multi-dimensionally explain the mechanism and treatment advantages of MT for CP.
A prospective randomized controlled clinical trial design was used to study the efficacy and safety of MT in the treatment of CP. One hundred and twenty cases of CP patients will be recruited and randomly divided into experimental group and control group according to 1:1. The control group: sodium hyaluronate; experimental group: MT added on the basis of the control group. Both groups will receive standard treatment for 4 weeks and followed up for 3 months. And at the same time, pay attention to its efficacy and safety indicators. Observation indicators include: the visual analogue scale pain score; the Western Ontario and McMaster Universities Arthritis Index scores; the Lysholm scores, and Bristol scores, adverse reactions, etc. Data analysis was performed using SPSS 25.0 software.
This study will precisely evaluate the effectiveness and safety of MT in the treatment of CP. The results of this experiment will provide more reliable clinical basis for the selection of MT for patients with CP.
髌骨软化症(CP)是一种常见的膝关节疼痛主要原因,其在普通人群中的患病率高达 36.2%,尤其在 30 至 40 岁的中年患者中(高达 50%)。使用手法治疗(MT)疏通膝关节周围的经络和肌肉,刺激相关穴位,可以在缓解疼痛和改善功能方面发挥重要作用。本研究旨在评估 MT 治疗 CP 的有效性、安全性,并进一步全面、完整、多维度地解释其机制和治疗优势。
采用前瞻性随机对照临床试验设计,研究 MT 治疗 CP 的疗效和安全性。将招募 120 例 CP 患者,并按照 1:1 的比例随机分为实验组和对照组。对照组:透明质酸钠;实验组:在对照组基础上采用 MT。两组均接受 4 周的标准治疗,并随访 3 个月。同时,注意其疗效和安全性指标。观察指标包括:视觉模拟评分疼痛量表;西安大略和麦克马斯特大学骨关节炎指数评分;Lysholm 评分和 Bristol 评分,不良反应等。采用 SPSS 25.0 软件进行数据分析。
本研究将精确评估 MT 治疗 CP 的有效性和安全性。该实验的结果将为 CP 患者选择 MT 提供更可靠的临床依据。